drugset / Trial / NCT05283980

Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement

NCT05283980

Phase 2/3 Active not recruiting 62 enrolled Beth Israel Deaconess Medical Center
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to determine whether administration of a pectoral nerve blocks (Pecs I and II) with 0.25% bupivacaine are more effective as compared to placebo to provide analgesia for cardiac implantable electronic device (CIED) placement in cardiac electrophysiology lab

Timeline

Start
2022-11-17
Primary completion
2025-03
Completion
2025-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 25 ml Other